MoneyWorks4Me

Panjon informs about revised financial results

20 Jun 2026 Evaluate
In continuation with the previous board meeting outcome held on Friday, 29 May, 2026 at 03:00 pm and in pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Panjon has informed that Board Meeting of the Company was held today i.e. on Friday , 29th May, 2026 at 03:00 pm at the registered office of the Company, the Board has considered and approved the following matters : The Audited Financial Results of the Company for the Quarter and Year ended March 31, 2026 along with Audited Reports; Appointed B. Jakhetiya & CO. Chartered Accountants (Membership No. 405010 - FRN NO. 005696C) as an Internal Auditor of the Company for the financial year 2026-2027. Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure-I. ‘The Meeting of the Board of Directors commenced at 03.00 PM and concluded at 5:30 PM.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..